Evan Rosenbaum, MD
Sarcoma Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
About Me
- Assistant Attending Physician
I am a medical oncologist with a specific focus on sarcomas of the bone and soft tissue. I became an oncologist to help patients through the challenges of a cancer diagnosis. Because sarcomas are rare, this can often lead to a layer of complexity and confusion on top of receiving a cancer diagnosis.
At Memorial Sloan Kettering Cancer Center, our team has a wealth of experience treating this group of rare diseases and is studying how to improve outcomes for all people with sarcoma.
Read more
Together with oncology nurses and dedicated office staff, I closely collaborate with my surgery, radiation oncology, interventional radiology, and pathology colleagues, among others, to identify the best possible treatment plan tailored for each patient and their unique diagnosis. In addition to focusing on standard of care treatment options, I am interested in finding novel treatments for people with sarcoma.
My research interests include modulating the immune system to help identify and fight tumors and to exploit the molecular characteristics of sarcomas with targeted therapies. I am actively involved in multiple research efforts to better understand the landscape of these diseases, identify promising new treatments, and study biomarkers of response.
A sarcoma medical oncologist is a cancer doctor who specializes in sarcoma. This includes soft tissue sarcomas (such as Ewing sarcoma and rhabdomyosarcoma) and benign (not cancer) growths that are like sarcoma.
My Specialties
- Bone and Soft Tissue Sarcomas
Education
- MD, Albert Einstein College of Medicine
Residencies
- Internal Medicine - Columbia University Medical Center
Awards and Honors
- Conquer Cancer Foundation Merit Award, American Society of Clinical Oncology Annual Meeting (2020)
- Young Investigator Award, American Society of Clinical Oncology Conquer Cancer Foundation (2019)
Fellowships
- Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Medical Oncology
- Internal Medicine
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Rosenbaum sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Rosenbaum
- A Phase 2 Study of Etrumadenant and Zimberelimab Immunotherapy to Treat Dedifferentiated Liposarcoma
- Clinical Trials Co-Investigated by Dr. Rosenbaum
- A Pilot Study of LN-144 Immunotherapy in People with Metastatic Uveal Melanoma
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Evan Rosenbaum discloses the following relationships and financial interests:
-
Iovance Biotherapeutics, Inc.
Equity
-
PMV Pharma
Equity
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].